Phreesia Form 4: Linetsky discloses sell-to-cover and 10b5-1 sales
Rhea-AI Filing Summary
Phreesia, Inc. insider David Linetsky reported sales of Common Stock to satisfy tax withholding on vested restricted stock units and under a trading plan. On 09/16/2025 he disposed of 2,165 shares in two non-discretionary sell-to-cover transactions at a weighted average price of $23.2844 per share, and on 09/17/2025 he disposed of 1,064 shares at $23.50 per share pursuant to a Rule 10b5-1 plan adopted 01/15/2025. After these transactions he beneficially owned 173,888 shares directly and 9,976 shares indirectly (by spouse). The Form 4 was signed by power of attorney on 09/18/2025.
Positive
- Timely disclosure of insider transactions filed on the Form 4 with signature by power of attorney on 09/18/2025
- Use of a Rule 10b5-1 plan for part of the sales indicates pre-established trading instructions
- Explicit explanation that disposals were to satisfy tax withholding on vested restricted stock units
Negative
- Net reduction in direct beneficial ownership following sales (total disposed: 3,229 shares)
- Shares sold include multiple prices; only a weighted average is provided publicly though the filer offers to supply detailed breakdowns on request
Insights
TL;DR: Insider sold small blocks of stock to cover taxes and under a pre-set trading plan; holdings remain substantial.
The filings show routine disposition tied to RSU settlement tax withholding and an executed 10b5-1 plan. Disposed amounts (3,229 shares total) represent a reduction but leave the reporting person with 173,888 shares direct and 9,976 indirect. Transactions were disclosed promptly and prices reported, including a weighted average for multi-price trades. From an investor-materiality perspective this is a routine insider liquidity event rather than a company-development signal.
TL;DR: Disclosure aligns with Section 16 requirements; use of power of attorney and 10b5-1 plan are standard governance practices.
The Form 4 documents compliance: a power of attorney signature, explanation that shares were sold under the issuer's mandatory sell-to-cover policy, and disclosure of a Rule 10b5-1 plan adoption date. The reporting includes a weighted average sale price range and an undertaking to provide detailed price breakdowns on request, which supports transparency. No other governance actions or departures are disclosed.